“…Few synthetic compounds have the same remarkable curative effects for the treatment of Chagas disease as megazol [2-amine-5-(1-methyl-5-nitro-2-imidazol-2-yl) 1,3,4 thiadiazole] (4) (Berkelhammer & Asato, 1968), a 1,3,4-thiadiazole nitroimidazole derivative that in experiments with mice infected with Colombian and T. cruzi strains showed higher rates of cure compared to the standard treatment using nitrofurazone (1), nifurtimox (2) and benznidazole (3) ( Table 1) (Filardi & Brener, 1982 All derivatives tested by Chauvière and colleagues (2003) produced a decrease in trypanocidal activity; however the molecular architecture of the prototype megazol (4) is the one that presents the best bioactivity profile against T. brucei, T. cruzi, L. infantum and L. donovani, without cytotoxicity to macrophage cells. Little is known about the metabolism of megazol, and despite its nitro-heterocyclic nature, some authors disagree on the metabolic reduction of the nitro group by nitroreductases as being critical for its trypanocidal activity.…”